Langsung menyang isi
Viva Cyte Platform Piranti Lunak Suite dening Livia Stevenin

Karya Viva Cyte Platform Piranti Lunak Suite dening Livia Stevenin minangka pemenang sing diajeni banget saka A' Design Award Perak 2025 sing bergengsi ing Kategori Kompetisi Desain Antarmuka, Interaksi lan Pengalaman Pangguna.


PerakAntarmuka· 2025

Viva Cyte Platform Piranti Lunak Suite

dening Livia Stevenin

Klien: Cellply

Pemenang A' Design Award Perak ing Kategori Antarmuka

56,621

Pemenang Penghargaan Terverifikasi

Verifikasi Status Penghargaan kanggo #168358

Warna

Desaine

Babagan Viva Cyte Platform Piranti Lunak Suite

Viva Cyte iku platform piranti lunak canggih sing dirancang kanggo nyederhanakake pangembangan terapi sel kanthi nggabungake otomasi, analisis throughput dhuwur, lan pengalaman pangguna sing intuitif. Platform iki kalebu Piranti Lunak Kontrol (CSW) kanggo ngatur tes biologis lan Piranti Lunak Analitik (ASW) kanggo njupuk wawasan sing migunani. Otomasi berbasis AI ngurangi kesalahan manungsa, ningkatake akurasi, lan ningkatake kegunaan, saengga ngidini peneliti navigasi alur kerja kompleks kanthi efisien nalika nyepetake kemajuan terapeutik.

Pangakuan

Babagan A' Design Award Perak

Viva Cyte Platform Piranti Lunak Suite menang A' Design Award Perak, pangenalan sing prestisius banget sing diparingake marang desain tingkat dhuwur, endah lan nggumunake. Pemenang Perak iku karya sing sumunar banget lan kreatif banget sing nggambarake kaprigelan, bakat lan kaweruh para desainer. Viva Cyte Platform Piranti Lunak Suite dikarepake dadi karya sing nggumunake, conto teladan, profesional banget lan inovatif banget. Desain sing menang A' Design Award Perak iki iku panemuan sing luar biasa banget lan dikagumi sing paring manfaat lan nyurung maju wates seni, sains, desain lan teknologi. Viva Cyte Platform Piranti Lunak Suite iku ciptaan sing akeh sing ngirenake sing nggugah kekarepan, nggawa perasaan positif lan nuwuhake gumun lan kagum.

Ing Mburi Desain

Kit Pers

Kredit, anggota tim lan detail teknis sing diwenehake dening desainer.

Sifat Unik
The project focused on UX/UI design for two integrated software solutions: Control Software (CSW) for launching and managing biological tests and Analytical Software (ASW) for extracting key insights from results. The design prioritizes scalability, usability, and automation and enables researchers to navigate complex workflows, configure tests, and analyze data with minimal effort, streamlining the entire process.
Ukuran & Kemasan
Design: Figma
Front-end: React JS
Design System: Bento
Tag
Cell therapy software, AI-driven automation, biomedical research, UX/UI design, data-driven, workflow optimization, healthcare innovation, regulatory compliance, user-centered design
Teknologi Produksi
We conducted extensive user research to design VivaCyte's software suite, including shadowing biologists in labs and interviewing end-users to understand their workflows and challenges. We also organized User Journey Mapping workshops, bringing together biologists and development teams to foster collaboration and gather diverse perspectives. The insights from these activities guided the creation of a custom design system, ensuring consistency and usability across the platforms.
Tantangan Desain
Designing VivaCyte posed challenges in balancing usability, automation, and compliance. Internally, we had to align complex biological workflows with intuitive design, ensuring seamless lab adoption. Externally, strict medical regulations require adherence to compliance standards. Limited industry precedents and evolving AI capabilities pushed us to innovate with user research, iterative prototyping, and AI-driven automation, overcoming barriers in technology and regulatory constraints.
Riset
We conducted user research to enhance VivaCyte’s usability and efficiency. Using shadowing and interviews, we observed lab workflows and identified pain points. Data was collected via on-site studies, journey mapping, and prototype testing with biologists and technicians. Insights led to features like printable maps and a guided setup walkthrough, reducing errors and improving efficiency. The research optimized workflows, accelerating cell therapy development.
Inspirasi
Inspired by the need to accelerate cancer cell therapies, VivaCyte was designed to streamline workflows, reduce human error, and enhance patient care. Recognizing the challenges of complex, labour-intensive workflows in cell therapy development, we sought to create a solution that integrates advanced automation, high-throughput analysis, and intuitive design. The design prioritizes usability and scalability, enabling researchers and clinicians to focus on innovation rather than constraints.
Durasi Proyek
The project started in January 2022 in Milan and finished in August 2024.
Alur Operasi
VivaCyte streamlines cell therapy workflows through an intuitive, automated interface. Users launch tests via the Control Software (CSW), which configures experiments that can be followed in real-time, while the Analytical Software (ASW) extracts biological insights and displays them. AI-driven automation minimizes errors, ensuring accuracy and efficiency. Designed for seamless interaction, it simplifies complex tasks, accelerates data analysis, and enhances usability.
Anggota Tim
Designer: Sara Bianchini
Designer: Livia Stevenin
Designer: Agnese Ragucci
Kredit Gambar
Image #1: Mockup: Designed by Freepik, Image: Livia Stevenin (UX/UI designer), Image #2: Livia Stevenin (UX/UI designer), Image #3: Livia Stevenin (UX/UI designer), Image #4: Livia Stevenin (UX/UI designer), Image #5: Livia Stevenin (UX/UI designer),

Disponsori

Jelajahi Ngluwihi Designers.org

Temokake produk, layanan lan kesempatan saka mitra iklan kita.

Desain Apik Pantes Nampa Pengakuan Gedhe

A' Design Award minangka penghargaan internasional sing dijuri kanggo desain apik. Melu A' Design Award kanggo entuk kesempatan nampa pengakuan meritokratis, reputasi, gengsi lan publisitas kanggo karyamu. Nominasikna karyamu kanggo A' Design Award lan saingan kanggo ngrebut A' Design Prize sing didambakake.

Nominasi